| High-density lipoprotein reduces the human monocyte inflammatory response AJ Murphy, KJ Woollard, A Hoang, N Mukhamedova, RA Stirzaker, ... Arteriosclerosis, thrombosis, and vascular biology 28 (11), 2071-2077, 2008 | 600 | 2008 |
| High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus BG Drew, SJ Duffy, MF Formosa, AK Natoli, DC Henstridge, SA Penfold, ... Circulation 119 (15), 2103-2111, 2009 | 491 | 2009 |
| Human immunodeficiency virus impairs reverse cholesterol transport from macrophages Z Mujawar, H Rose, MP Morrow, T Pushkarsky, L Dubrovsky, ... PLoS biology 4 (11), e365, 2006 | 399 | 2006 |
| Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque JA Shaw, A Bobik, A Murphy, P Kanellakis, P Blombery, N Mukhamedova, ... Circulation research 103 (10), 1084-1091, 2008 | 334 | 2008 |
| Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux AC Calkin, BG Drew, A Ono, SJ Duffy, MV Gordon, SM Schoenwaelder, ... Circulation 120 (21), 2095-2104, 2009 | 258 | 2009 |
| Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein AI in in vitro and in vivo models of inflammation AJ Murphy, KJ Woollard, A Suhartoyo, RA Stirzaker, J Shaw, D Sviridov, ... Arteriosclerosis, thrombosis, and vascular biology 31 (6), 1333-1341, 2011 | 254 | 2011 |
| Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes S Patel, BG Drew, S Nakhla, SJ Duffy, AJ Murphy, PJ Barter, KA Rye, ... Journal of the American College of Cardiology 53 (11), 962-971, 2009 | 246 | 2009 |
| Dynamics of reverse cholesterol transport: protection against atherosclerosis D Sviridov, P Nestel Atherosclerosis 161 (2), 245-254, 2002 | 205 | 2002 |
| HIV infection and high density lipoprotein metabolism H Rose, J Hoy, I Woolley, U Tchoua, M Bukrinsky, A Dart, D Sviridov Atherosclerosis 199 (1), 79-86, 2008 | 200 | 2008 |
| The macrophage: the intersection between HIV infection and atherosclerosis SM Crowe, CLV Westhorpe, N Mukhamedova, A Jaworowski, D Sviridov, ... Journal of leukocyte biology 87 (4), 589-598, 2010 | 197 | 2010 |
| Advanced glycation of apolipoprotein AI impairs its anti-atherogenic properties A Hoang, AJ Murphy, MT Coughlan, MC Thomas, JM Forbes, R O’brien, ... Diabetologia 50, 1770-1779, 2007 | 181 | 2007 |
| Physical fitness and reverse cholesterol transport B Olchawa, BA Kingwell, A Hoang, L Schneider, O Miyazaki, P Nestel, ... Arteriosclerosis, thrombosis, and vascular biology 24 (6), 1087-1091, 2004 | 156 | 2004 |
| The anti inflammatory effects of high density lipoproteins AJ Murphy, JPF Chin-Dusting, D Sviridov, KJ Woollard Current medicinal chemistry 16 (6), 667-675, 2009 | 150 | 2009 |
| Expression of caveolin-1 enhances cholesterol efflux in hepatic cells Y Fu, A Hoang, G Escher, RG Parton, Z Krozowski, D Sviridov Journal of Biological Chemistry 279 (14), 14140-14146, 2004 | 146 | 2004 |
| 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice MJA Amar, W D'Souza, S Turner, S Demosky, D Sviridov, J Stonik, ... Journal of Pharmacology and Experimental Therapeutics 334 (2), 634-641, 2010 | 144 | 2010 |
| Antiatherogenic Functionality of High Density Lipoprotein: How Much versus How Gooden-subtitle= D Sviridov, N Mukhamedova, AT Remaley, J Chin-Dusting, P Nestel Journal of atherosclerosis and thrombosis 15 (2), 52-62, 2008 | 143 | 2008 |
| HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment H Rose, I Woolley, J Hoy, A Dart, B Bryant, A Mijch, D Sviridov Metabolism 55 (1), 90-95, 2006 | 134 | 2006 |
| Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration A Masedunskas, JA King, F Tan, R Cochran, T Stevens, D Sviridov, ... FEBS letters 580 (11), 2637-2645, 2006 | 132 | 2006 |
| Specific NLRP3 inhibition protects against diabetes-associated atherosclerosis A Sharma, JSY Choi, N Stefanovic, A Al-Sharea, DS Simpson, ... Diabetes 70 (3), 772-787, 2021 | 121 | 2021 |
| Asymmetry in the lipid affinity of bihelical amphipathic peptides: a structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides AA Sethi, JA Stonik, F Thomas, SJ Demosky, M Amar, E Neufeld, ... Journal of Biological Chemistry 283 (47), 32273-32282, 2008 | 115 | 2008 |